Not surprisingly, the trend of recommending and administering intravenous glutathione has increased within months of it becoming available, despite the potential adverse effects and lack of evidence
References Picardi A, Gigantesco A, Tarolla E, Stoppioni V, Cerbo R, Cremonte M, et al
Obesity is a chronic, biologic disease, and different patients need different tools
GLP-1 receptor agonists are authorised for the treatment of diabetes 1 or for weight management under certain conditions 2 or both 3
Quick Answer: Semaglutide does not directly cause kidney stones, but its gastrointestinal side effects may lead to dehydration, which increases stone formation risk
Blood pressure medications: May be reduced as blood pressure improves with weight loss